You‐Hong Cui

6.2k citations

95 papers · 4.8k indexed · h-index 41

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Oncology top 1%
- Cancer Cells and Metastasis

Papers in

Cancer Research 27
- Cancer, Hypoxia, and Metabolism 10
- MicroRNA in disease regulation 8
Oncology 42
- Cancer Cells and Metastasis 22

Co-authors: Xiu‐Wu Bian Cheng Qian Ji Ming Wang Yi‐Fang Ping Shi‐Cang Yu Yingying Le Lang Yang Senlin Xu
Journals: Cancer Letters (7 papers)International Immunopharmacology (6 papers)The Journal of Pathology (5 papers)The Journal of Immunology (5 papers)PLoS ONE (5 papers)
Partner nations: China United States Saudi Arabia

In The Last Decade

You‐Hong Cui

95 papers receiving 4.8k citations

Peers

Countries citing papers authored by You‐Hong Cui

Since Specialization

Citations

This map shows the geographic impact of You‐Hong Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by You‐Hong Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites You‐Hong Cui more than expected).

Fields of papers citing papers by You‐Hong Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by You‐Hong Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by You‐Hong Cui. The network helps show where You‐Hong Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside You‐Hong Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with You‐Hong Cui Line = papers co-authored together You‐Hong Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis The Journal of Pathology ·Hong Zhou, Yanxia Wang, (unknown), Min Wu, Chunyan Lan, Dongfang Xiang, Ruili Cai, Qinghua Ma, Jingya Miao, Xuanyu Fang, Junjie Wang, Dan Luo, Zhicheng He, You‐Hong Cui, Ping Liang, (unknown), (unknown), Xiu‐Wu Bian	2024	7
2	ZYX promotes invasion and metastasis of gastric cancer cells via WNK1/SNAI1axis Genes & Diseases ·Yi Jiang, Dongfang Xiang, Xianmei Wen, Mingmin He, Yan Qin, Xiao‐Xue Yao, Zexuan Yan, X. Geng, Yong Ren, Xiongwei Cai, You‐Hong Cui, Yan Wang	2023	1
3	The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression Cancer Communications ·Ye Yuan, Lihong Wang, Xianxian Zhao, Jiao Wang, Mengsi Zhang, Qinghua Ma, Sen Wei, Zexuan Yan, Yue Cheng, Xiaohong Chen, Hongbo Zou, Jia Ge, Yan Wang, Xia Zhang, You‐Hong Cui, Tao Luo, Xiu‐Wu Bian	2022	19
4	Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma Stem Cell Research & Therapy ·Ye Yuan, Zexuan Yan, Jingya Miao, Ruili Cai, Mengsi Zhang, Yanxia Wang, Lihong Wang, Weiqi Dang, Di Wang, Dongfang Xiang, Yan Wang, Peng Zhang, You‐Hong Cui, Xiu‐Wu Bian, Qinghua Ma	2019	34
5	Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma Journal of Cellular and Molecular Medicine ·Yixing Gao, Erlong Zhang, Bao Liu, Kai Zhou, Shu He, Lan Feng, Gang Wu, Mianfu Cao, Haibo Wu, You‐Hong Cui, Xia Zhang, Xindong Liu, Yan Wang, Yuqi Gao, Xiu‐Wu Bian	2019	15
6	Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma The Journal of Pathology ·Juan Tan, Mei Liu, Junying Zhang, Yueliang Yao, Yanxia Wang, Yong Lin, Kang Won Song, Jiao Tan, Jinrong Wu, You‐Hong Cui, Yan Wang, Xiu‐Wu Bian	2018	11
7	AEBP1 promotes epithelial-mesenchymal transition of gastric cancer cells by activating the NF-κB pathway and predicts poor outcome of the patients Scientific Reports ·Junyan Liu, Lei Jiang, Jiajia Liu, Tao He, You‐Hong Cui, Feng Qian, Pei-wu Yu	2018	41
8	NDGA-P21, a novel derivative of nordihydroguaiaretic acid, inhibits glioma cell proliferation and stemness Laboratory Investigation ·Qiwen Zhao, Yong Lin, Chang-Rong Xu, Yueliang Yao, You‐Hong Cui, Xia Zhang, Xiu‐Wu Bian	2017	8
9	miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma Clinical Cancer Research ·Yu Shi, Cong Chen, Shizhu Yu, Qing Liu, Jun Rao, Huarong Zhang, Hualiang Xiao, Tiwei Fu, Hua Long, Zhicheng He, Kai Zhou, Xiaohong Yao, You‐Hong Cui, Xia Zhang, Yi‐Fang Ping, Xiu‐Wu Bian	2015	49
10	SEMA3F prevents metastasis of colorectal cancer by PI3K–AKT‐dependent down‐regulation of the ASCL2–CXCR4 axis The Journal of Pathology ·Zhihang Zhou, Jun Rao, Jing Yang, Feng Wu, Juan Tan, Senlin Xu, Yanqing Ding, Na Zhan, Xu‐Gang Hu, You‐Hong Cui, Xia Zhang, Weiguo Dong, Xindong Liu, Xiu‐Wu Bian	2015	37
11	Primate-Specific miR-663 Functions as a Tumor Suppressor by Targeting PIK3CD and Predicts the Prognosis of Human Glioblastoma Clinical Cancer Research ·Yu Shi, Cong Chen, Xia Zhang, Qing Liu, Jinling Xu, Huarong Zhang, Xiaohong Yao, Tao Jiang, Zhicheng He, Yong Ren, Wei Cui, Chuan Xu, Ling Liu, You‐Hong Cui, Shizhu Yu, Yi‐Fang Ping, Xiu‐Wu Bian	2014	81
12	Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes Cancer Research ·Leina Ma, Jia Liu, Limei Liu, Guangjie Duan, Qingliang Wang, Yanmin Xu, X Y Feng, Juanjuan Shan, Junjie Shen, Zhi Yang, Ping Bie, You‐Hong Cui, Xiu‐Wu Bian, Jesús Prìeto, Matías A. Ávila, Cheng Qian	2014	74
13	Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells Cancer Research ·Bin Wang, Qiang Wang, Zhe Wang, Jun Jiang, Shi‐Cang Yu, Yi‐Fang Ping, Jing Yang, Senlin Xu, Xian-Zong Ye, Chuan Xu, Lang Yang, Cheng Qian, Ji Ming Wang, You‐Hong Cui, Xia Zhang, Xiu‐Wu Bian	2014	174
14	ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis BMC Cancer ·Ying Liu, Donglai Lv, Jiang‐Jie Duan, Senlin Xu, Jingfang Zhang, Xiaojun Yang, Xia Zhang, You‐Hong Cui, Xiu‐Wu Bian, Shi‐Cang Yu	2014	88
15	A Novel Zebrafish Xenotransplantation Model for Study of Glioma Stem Cell Invasion PLoS ONE ·Xiaojun Yang, Wei Cui, Gu Ai, Chuan Xu, Shi‐Cang Yu, Tingting Li, You‐Hong Cui, Xia Zhang, Xiu‐Wu Bian	2013	85
16	Endogenous Axon Guiding Chemorepulsant Semaphorin-3F Inhibits the Growth and Metastasis of Colorectal Carcinoma Clinical Cancer Research ·Feng Wu, Qi Zhou, Jing Yang, Guangjie Duan, Juanjuan Ou, Rong Zhang, Feng Pan, Qiuping Peng, Hong Kee Tan, Yi‐Fang Ping, You‐Hong Cui, Cheng Qian, Xiao-Chu Yan, Xiu‐Wu Bian	2011	41
17	The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell‐mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling The Journal of Pathology ·Yi‐Fang Ping, Xiaohong Yao, Jiang Jian-yong, Lintao Zhao, Shi‐Cang Yu, Tao Jiang, Marie CM Lin, Jian‐hong Chen, Bin Wang, Rong Zhang, You‐Hong Cui, Cheng Qian, Ji Ming Wang, Xiu‐Wu Bian	2011	191
18	Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNFα response and p53 activity Cellular and Molecular Immunology ·Weizhong Li, Gefei Wang, Heng Zhang, Gang Xin, Dangui Zhang, Jun Zeng, Xiaoxuan Chen, Yanxuan Xu, You‐Hong Cui, Kangsheng Li	2010	28
19	The green tea polyphenol (−)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR International Immunopharmacology ·Jingjing Zhu, Oumei Wang, Lingfei Ruan, Xinwei Hou, You‐Hong Cui, Jiming Wang, Yingying Le	2009	18
20	Humanin, a Newly Identified Neuroprotective Factor, Uses the G Protein-Coupled Formylpeptide Receptor-Like-1 as a Functional Receptor The Journal of Immunology ·Guoguang Ying, Pablo Iribarren, Ye Zhou, Wanghua Gong, Ning Zhang, Zu-Xi Yu, Yingying Le, You‐Hong Cui, Ji Ming Wang	2004	191

About You‐Hong Cui

You‐Hong Cui is a scholar working on Cancer Research, Oncology, Genetics, Immunology and Molecular Biology, having authored 95 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (22 papers), Glioma Diagnosis and Treatment (13 papers), Angiogenesis and VEGF in Cancer (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), Immune cells in cancer (9 papers), S100 Proteins and Annexins (8 papers), MicroRNA in disease regulation (8 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.7k citations), Genetics (532 citations), Immunology (1.1k citations) and Molecular Biology (2.8k citations). You‐Hong Cui has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Xiu‐Wu Bian, Cheng Qian, Ji Ming Wang, Yi‐Fang Ping, Shi‐Cang Yu, Yingying Le, Lang Yang, Senlin Xu, Wanghua Gong and Zhi Yang. Their work appears in journals such as Cancer Letters, International Immunopharmacology, The Journal of Pathology, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact